Search research articles
Contact Us
Filters
Showing results (41-50 of 102) with videos related to
Page
of 11
Sort By:
Current Cancer Drug Targets
|
May 16, 2009
HER-2 signaling and inhibition in breast cancer
B C Browne, N O'Brien, M J Duffy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1995
Carboplatin and etoposide in metastatic breast cancer
J Crown, N Hamilton, G Raptis, et al.
Neurology
|
July 27, 2005
Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy
J P O'Dwyer, C Clabby, J Crown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
High-dose chemotherapy of breast cancer: current status and developmental strategies
J Crown, G Raptis, N Hamilton, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 30, 2020
Differentiation of intracranial meningioma from dural metastasis with somatostatin receptor scintigraphy: An underutilised solution to a common problem
S Liddy, J Duignan, A Haughey, et al.
The Canadian Journal of Oncology
|
December 1, 1995
High-dose chemotherapy of breast cancer
J Crown, G Raptis, N Hamilton, et al.
International Journal of Oncology
|
July 24, 2015
Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
T Mahgoub, A J Eustace, D M Collins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
D M Collins, N O'Donovan, P M McGowan, et al.
British Journal of Cancer
|
May 14, 2008
SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue
S Kennedy, M Clynes, P Doolan, et al.
Breast Cancer Research and Treatment
|
December 28, 2014
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
N Elster, D M Collins, S Toomey, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 102) with videos related to
Sort By:
Page
of 11
Current Cancer Drug Targets
|
May 16, 2009
HER-2 signaling and inhibition in breast cancer
B C Browne, N O'Brien, M J Duffy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1995
Carboplatin and etoposide in metastatic breast cancer
J Crown, N Hamilton, G Raptis, et al.
Neurology
|
July 27, 2005
Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy
J P O'Dwyer, C Clabby, J Crown, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1995
High-dose chemotherapy of breast cancer: current status and developmental strategies
J Crown, G Raptis, N Hamilton, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 30, 2020
Differentiation of intracranial meningioma from dural metastasis with somatostatin receptor scintigraphy: An underutilised solution to a common problem
S Liddy, J Duignan, A Haughey, et al.
The Canadian Journal of Oncology
|
December 1, 1995
High-dose chemotherapy of breast cancer
J Crown, G Raptis, N Hamilton, et al.
International Journal of Oncology
|
July 24, 2015
Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
T Mahgoub, A J Eustace, D M Collins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines
D M Collins, N O'Donovan, P M McGowan, et al.
British Journal of Cancer
|
May 14, 2008
SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue
S Kennedy, M Clynes, P Doolan, et al.
Breast Cancer Research and Treatment
|
December 28, 2014
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
N Elster, D M Collins, S Toomey, et al.
Page
of 11